MAPT and Alzheimer disease: High levels of tau protein with acetylation at the Lys163, Lys174, and Lys180 sites, which inhibits the degradation of hyperphosphorylated tau protein and thus contributes to the accumulation of phosphorylated tau protein, are detected in the brains of patients with mild to moderate AD.